Groundbreaking test identifies gene expression pattern consistent with fibromyalgia syndrome, providing information that can speed pace of diagnosis

Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia, a pioneering blood test that uses RNA analysis to help health care providers accurately and quickly detect fibromyalgia syndrome.

IsolateFibromyalgia uses a simple blood draw to detect, with 94 percent accuracy, if a patient’s gene expression pattern is consistent with fibromyalgia syndrome. Providers who suspect fibromyalgia in a patient can order the test at IQuityLabs.com, with results delivered back to the provider within seven days of receiving the sample in the laboratory — reducing by months and even years the time it currently takes to diagnose the disease.

Read more of this article from News Medical Life Sciences.